Vetigenics LLC

PHILADELPHIA, PA · Biotech · Private

Recombinant canine-derived antibodies for cancer immunotherapy research and therapeutic development

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Biotech
Headquarters
PHILADELPHIA, PA
Total capital
$4.4M
Federal grants
$2.1M
2 awards
Rank in peer group#15 of 326
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
$2.4M
2 awards · Health and Human S
Rank in Biotech#127 of 4373
Granted patents
0
1 pending

Capital timeline

2018201920202021FEDERAL ↑EQUITY ↓Cumulative $2.4M$355K$2M
2018201920202021FEDERAL ↑EQUITY ↓Cumulative $2.4M$355K$2M

Latest events

  • Federal contractHealth and Human S · Moonshot - Topic 372 - Development And Validation Of Non-mouse Reagents To Enable Preclinical Development Of Novel Therapeutics.$2M
  • Federal contractHealth and Human S · Igf::ot::igf Topic 372: Development And Validation Of Canine Scfvs For Pre-clinical Development Of Targeted Therapeutics - Moonshot$355K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

2 records have no date or no amount, so they aren’t placed on the timeline.

Standing among 326 peers

Line = median

Biotech · Molecule

  • Federal grants#15 · top 5%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 1
  • PendingCanine Monoclonal Antibodies Against Canine Cytotoxic T Lymphocyte Associated Protein 4 (CTLA-4)USPTOApplication PCTUS2022025614

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .